CRO

Quintiles credits IT advances for big deals; Merck Millipore eyes price hike;

> Quintiles CIO Richard Thomas says the CRO has boosted its IT capabilities of late, and that has helped bring in about $400 million in new business. Report

> CMO Merck Millipore is planning to hike its rates between 4% and 6% next year, citing rising costs. News

> Icon ($ICLR) is expanding its early-phase imaging services, unveiling new processes to save time in drug development. More

> AMRI has expanded its clinical supply agreement with Shire ($SHPG) for another 5 years. Neither company disclosed financial terms. Article

> Chinese CRO Tigermed is turning to Merge Healthcare ($MRGE) to streamline its clinical trial management. Release